Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
1.
Methods Mol Biol ; 2511: 321-332, 2022.
Article in English | MEDLINE | ID: mdl-35838971

ABSTRACT

Inflammatory diseases caused by infectious agents such as the SARS-CoV-2 virus can lead to impaired reductive-oxidative (REDOX) balance and disrupted mitochondrial function. Peripheral blood mononuclear cells (PBMCs) provide a useful model for studying the effects of inflammatory diseases on mitochondrial function but can be limited by the need to store these cells by cryopreservation prior to assay. Here, we describe a method for improving and determining PBMC viability with normalization of values to number of living cells. The approach can be applied not only to PBMC samples derived from patients with diseases marked by an altered inflammatory response such as viral infections.


Subject(s)
COVID-19 , Leukocytes, Mononuclear , Cryopreservation/methods , Humans , Leukocytes, Mononuclear/metabolism , Mitochondria , Respiration , SARS-CoV-2
2.
Front Genet ; 12: 748627, 2021.
Article in English | MEDLINE | ID: mdl-34745222

ABSTRACT

Autism spectrum disorder (ASD), characterized by profound impairment in social interactions and communication skills, is the most common neurodevelopmental disorder. Many studies on the mechanisms underlying the development of ASD have focused on the serotonergic system; however, these studies have failed to completely elucidate the mechanisms. We previously identified N-ethylmaleimide-sensitive factor (NSF) as a new serotonin transporter (SERT)-binding protein and described its importance in SERT membrane trafficking and uptake in vitro. In the present study, we generated Nsf +/- mice and investigated their behavioral, neurotransmitter, and neurophysiological phenotypes in vivo. Nsf +/- mice exhibited abnormalities in sociability, communication, repetitiveness, and anxiety. Additionally, Nsf loss led to a decrease in membrane SERT expression in the raphe and accumulation of glutamate alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors at the synaptic membrane surface in the hippocampal CA1 region. We found that postsynaptic density and long-term depression were impaired in the hippocampal CA1 region of Nsf +/- mice. Taken together, these findings demonstrate that NSF plays a role in synaptic plasticity and glutamatergic and serotonergic systems, suggesting a possible mechanism by which the gene is linked to the pathophysiology of autistic behaviors.

3.
Cell Rep ; 35(2): 108985, 2021 04 13.
Article in English | MEDLINE | ID: mdl-33852843

ABSTRACT

Decreased cognitive performance is a hallmark of brain aging, but the underlying mechanisms and potential therapeutic avenues remain poorly understood. Recent studies have revealed health-protective and lifespan-extending effects of dietary spermidine, a natural autophagy-promoting polyamine. Here, we show that dietary spermidine passes the blood-brain barrier in mice and increases hippocampal eIF5A hypusination and mitochondrial function. Spermidine feeding in aged mice affects behavior in homecage environment tasks, improves spatial learning, and increases hippocampal respiratory competence. In a Drosophila aging model, spermidine boosts mitochondrial respiratory capacity, an effect that requires the autophagy regulator Atg7 and the mitophagy mediators Parkin and Pink1. Neuron-specific Pink1 knockdown abolishes spermidine-induced improvement of olfactory associative learning. This suggests that the maintenance of mitochondrial and autophagic function is essential for enhanced cognition by spermidine feeding. Finally, we show large-scale prospective data linking higher dietary spermidine intake with a reduced risk for cognitive impairment in humans.


Subject(s)
Aging/genetics , Autophagy-Related Protein 7/genetics , Cognitive Dysfunction/genetics , Dietary Supplements , Protein Kinases/genetics , Spermidine/pharmacology , Ubiquitin-Protein Ligases/genetics , Aging/metabolism , Animals , Autophagy-Related Protein 7/metabolism , Brain/cytology , Brain/drug effects , Brain/growth & development , Brain/metabolism , Cognition/drug effects , Cognition/physiology , Cognitive Dysfunction/metabolism , Cognitive Dysfunction/physiopathology , Cognitive Dysfunction/prevention & control , Drosophila melanogaster/drug effects , Drosophila melanogaster/genetics , Drosophila melanogaster/growth & development , Drosophila melanogaster/metabolism , Female , Gene Expression Regulation , Humans , Learning/drug effects , Learning/physiology , Male , Mice , Mitochondria/drug effects , Mitochondria/genetics , Mitochondria/metabolism , Neurons/drug effects , Neurons/metabolism , Oxidative Phosphorylation/drug effects , Protein Kinases/metabolism , Signal Transduction , Spatial Memory/drug effects , Spatial Memory/physiology , Ubiquitin-Protein Ligases/metabolism
4.
Neurosci Lett ; 743: 135563, 2021 01 19.
Article in English | MEDLINE | ID: mdl-33359046

ABSTRACT

N-myc downstream-regulated gene 2 (NDRG2), a member of the NDRG family, has multiple functions in cell proliferation, differentiation, and stress responses, and is predominantly expressed by astrocytes in the central nervous system. Previous studies including ours demonstrated that NDRG2 is involved in various central nervous system pathologies. However, the significance of NDRG2 in neurodevelopment is not fully understood. Here, we investigated the expression profile of NDRG2 during postnatal brain development, the role of NDRG2 in social behavior, and transcriptome changes in the brain of NDRG2-deficient mice. NDRG2 expression in the brain increased over time from postnatal day 1 to adulthood. Deletion of NDRG2 resulted in abnormal social behavior, as indicated by reduced exploratory activity toward a novel mouse in a three-chamber social interaction test. Microarray analysis identified genes differentially expressed in the NDRG2-deficient brain, and upregulated gene expression of Bmp4 and Per2 was confirmed by quantitative PCR analysis. Expression of both these genes and the encoded proteins increased over time during postnatal brain development, similar to NDRG2. Gene expression of Bmp4 and Per2 was upregulated in cultured astrocytes isolated from NDRG2-deficient mice. These results suggest that NDRG2 contributes to brain development required for proper social behavior by modulating gene expression in astrocytes.


Subject(s)
Adaptor Proteins, Signal Transducing/deficiency , Adaptor Proteins, Signal Transducing/genetics , Social Behavior , Animals , Bone Morphogenetic Protein 4/biosynthesis , Bone Morphogenetic Protein 4/genetics , Cells, Cultured , Gene Expression , Locomotion/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Period Circadian Proteins/biosynthesis , Period Circadian Proteins/genetics
5.
Sci Rep ; 10(1): 20602, 2020 11 26.
Article in English | MEDLINE | ID: mdl-33244118

ABSTRACT

This case-control study aimed to assess oxidative stress alterations in autism spectrum disorder (ASD). We used the MULTIS method, an electron spin resonance-based technique measuring multiple free radical scavenging activities simultaneously, in combination with conventional oxidative stress markers to investigate the ability of this MULTIS approach as a non-behavioural diagnostic tool for children with ASD. Serum samples of 39 children with ASD and 58 age-matched children with typical development were analysed. The ASD group showed decreased hydroxyl radical (·OH) and singlet oxygen scavenging activity with increased serum coenzyme Q10 oxidation rate, indicating a prooxidative tendency in ASD. By contrast, scavenging activities against superoxide (O2·-) and alkoxyl radical (RO·) were increased in the ASD group suggesting antioxidative shifts. In the subgroup analysis of 6-year-olds or younger, the combination of ·OH, O2·-, and RO· scavenging activities predicted ASD with high odds ratio (50.4), positive likelihood (12.6), and percentage of correct classification (87.0%). Our results indicate that oxidative stress in children with ASD is not simply elevated but rather shows a compensatory shift. MULTIS measurements may serve as a very powerful non-behavioural tool for the diagnosis of ASD in children.


Subject(s)
Autism Spectrum Disorder/diagnosis , Oxidative Stress , Autism Spectrum Disorder/blood , Biomarkers/blood , Case-Control Studies , Child , Child, Preschool , Female , Humans , Male , Reactive Oxygen Species/blood , Ubiquinone/analogs & derivatives , Ubiquinone/blood
6.
Nat Commun ; 11(1): 4029, 2020 08 12.
Article in English | MEDLINE | ID: mdl-32788597

ABSTRACT

In autosomal dominant optic atrophy (ADOA), caused by mutations in the mitochondrial cristae biogenesis and fusion protein optic atrophy 1 (Opa1), retinal ganglion cell (RGC) dysfunction and visual loss occur by unknown mechanisms. Here, we show a role for autophagy in ADOA pathogenesis. In RGCs expressing mutated Opa1, active 5' AMP-activated protein kinase (AMPK) and its autophagy effector ULK1 accumulate at axonal hillocks. This AMPK activation triggers localized hillock autophagosome accumulation and mitophagy, ultimately resulting in reduced axonal mitochondrial content that is restored by genetic inhibition of AMPK and autophagy. In C. elegans, deletion of AMPK or of key autophagy and mitophagy genes normalizes the axonal mitochondrial content that is reduced upon mitochondrial dysfunction. In conditional, RGC specific Opa1-deficient mice, depletion of the essential autophagy gene Atg7 normalizes the excess autophagy and corrects the visual defects caused by Opa1 ablation. Thus, our data identify AMPK and autophagy as targetable components of ADOA pathogenesis.


Subject(s)
Autophagy , Optic Atrophy, Autosomal Dominant/complications , Vision Disorders/complications , Adenylate Kinase/metabolism , Animals , Autophagy/genetics , Axons/pathology , Caenorhabditis elegans/metabolism , Disease Models, Animal , Enzyme Activation , GTP Phosphohydrolases/genetics , Mice, Inbred C57BL , Mice, Knockout , Mitochondria/metabolism , Mitophagy , Mutation/genetics , Phosphorylation , Retinal Ganglion Cells/pathology
7.
EBioMedicine ; 58: 102917, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32739868

ABSTRACT

BACKGROUND: Abnormalities of lipid metabolism contributing to the autism spectrum disorder (ASD) pathogenesis have been suggested, but the mechanisms are not fully understood. We aimed to characterize the lipid metabolism in ASD and to explore a biomarker for clinical evaluation. METHODS: An age-matched case-control study was designed. Lipidomics was conducted using the plasma samples from 30 children with ASD compared to 30 typical developmental control (TD) children. Large-scale lipoprotein analyses were also conducted using the serum samples from 152 children with ASD compared to 122 TD children. Data comparing ASD to TD subjects were evaluated using univariate (Mann-Whitney test) and multivariate analyses (conditional logistic regression analysis) for main analyses using cofounders (diagnosis, sex, age, height, weight, and BMI), Spearman rank correlation coefficient, and discriminant analyses. FINDINGS: Forty-eight significant metabolites involved in lipid biosynthesis and metabolism, oxidative stress, and synaptic function were identified in the plasma of ASD children by lipidomics. Among these, increased fatty acids (FAs), such as omega-3 (n-3) and omega-6 (n-6), showed correlations with clinical social interaction score and ASD diagnosis. Specific reductions of very-low-density lipoprotein (VLDL) and apoprotein B (APOB) in serum of ASD children also were found by large-scale lipoprotein analysis. VLDL-specific reduction in ASD was correlated with APOB, indicating VLDL-specific dyslipidaemia associated with APOB in ASD children. INTERPRETATION: Our results demonstrated that the increases in FAs correlated positively with social interaction are due to VLDL-specific degradation, providing novel insights into the lipid metabolism underlying ASD pathophysiology. FUNDING: This study was supported mainly by MEXT, Japan.


Subject(s)
Autism Spectrum Disorder/psychology , Dyslipidemias/blood , Fatty Acids/blood , Lipidomics/methods , Lipoproteins, VLDL/blood , Adolescent , Apolipoprotein B-100/blood , Autism Spectrum Disorder/blood , Case-Control Studies , Child , Child, Preschool , Female , Humans , Japan , Logistic Models , Male , Metabolomics , Oxidative Stress , Social Interaction
8.
Nagoya J Med Sci ; 82(1): 93-99, 2020 Feb.
Article in English | MEDLINE | ID: mdl-32273637

ABSTRACT

Thoracic wall nerve blocks reduce postoperative acute pain after breast cancer surgery (BCS); however, their short-term effects and the most effective technique remain unclear. To compare the effects of pectoral nerve block type-2 (Pecs II block) and serratus plane block for postoperative short-term analgesia, we retrospectively reviewed 43 BCS patients who underwent Pecs II block (n=22) or serratus plane block (n=21). The primary outcome was the proportion of patients with no complaints of pain 2 months post-BCS. The odds ratio (OR) was assessed, adjusting for axillary lymph node dissection. The secondary outcomes were pain severity 24 hours and 2 months post-operation using the numerical rating scale score, and morphine consumption within 24 hours. The proportion of patients without pain 2 months post-BCS was significantly less with Pecs II block than in patients with serratus plane block (55% vs. 19%, adjusted OR, 5.04; 95% confidence interval, 1.26-20.07; P=0.02); the median [interquartile range] score for pain 2 months post-operation was also significantly lower with Pecs II block (Pecs II block 0.5 [0-1] vs. serratus plane block 1 [1-2]); P=0.03). Regarding post-BCS acute analgesia, the median [interquartile range] postoperative 24-hour pain score was 2 [1-3] and 3 [1.5-3.5], and the median morphine consumption within 24 hours was 1.5 [0.75-5.5] and 3 [1.5-10] mg in Pecs II block and serratus plane block (P=0.47 and P=0.11), respectively. This study suggests that Pecs II block prevents short-term post-BCS pain better than serratus plane block. However, further studies are needed in order to support this finding.


Subject(s)
Breast Neoplasms/surgery , Mastectomy , Nerve Block/methods , Pain Management/methods , Pain, Postoperative/prevention & control , Thoracic Nerves , Adult , Aged , Female , Humans , Mastectomy/adverse effects , Middle Aged , Nerve Block/adverse effects , Pain Management/adverse effects , Pain, Postoperative/diagnosis , Pain, Postoperative/etiology , Retrospective Studies , Treatment Outcome
9.
J Clin Invest ; 129(4): 1533-1535, 2019 03 18.
Article in English | MEDLINE | ID: mdl-30882369

ABSTRACT

Motoneurons are particularly sensitive to mutations in mitofusin-2 (MFN2) that cause the neurological disorder Charcot-Marie-Tooth disease type 2A (CMT2A). MFN2 is a mitochondrial outer membrane protein that, together with its homologue MFN1, fuses mitochondria in most tissues. In this issue of the JCI, Zhou and colleagues show that increasing MFN1 expression in neurons can curtail neurological defects in a CMT2A mouse model. These results show that the ratio of MFN1 to MFN2 can explain the tissue specificity of CMT2A and indicate that augmentation of MFN1 in the nervous system has potential as a possible therapeutic strategy for CMT2A.


Subject(s)
Charcot-Marie-Tooth Disease , Animals , GTP Phosphohydrolases/genetics , Membrane Proteins/genetics , Mice , Mitochondria , Mutation
10.
Sci Rep ; 9(1): 4305, 2019 03 13.
Article in English | MEDLINE | ID: mdl-30867511

ABSTRACT

The essential involvement of phosphoinositides in synaptic plasticity is well-established, but incomplete knowledge of the downstream molecular entities prevents us from understanding their signalling cascades completely. Here, we determined that Phldb2, of which pleckstrin-homology domain is highly sensitive to PIP3, functions as a phosphoinositide-signalling mediator for synaptic plasticity. BDNF application caused Phldb2 recruitment toward postsynaptic membrane in dendritic spines, whereas PI3K inhibition resulted in its reduced accumulation. Phldb2 bound to postsynaptic scaffolding molecule PSD-95 and was crucial for localization and turnover of PSD-95 in the spine. Phldb2 also bound to GluA1 and GluA2. Phldb2 was indispensable for the interaction between NMDA receptors and CaMKII, and the synaptic density of AMPA receptors. Therefore, PIP3-responsive Phldb2 is pivotal for induction and maintenance of LTP. Memory formation was impaired in our Phldb2-/- mice.


Subject(s)
Carrier Proteins/metabolism , Disks Large Homolog 4 Protein/metabolism , Long-Term Potentiation/physiology , Membrane Proteins/metabolism , Phosphatidylinositol Phosphates/metabolism , Receptors, AMPA/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Animals , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Memory , Mice , Neuronal Plasticity , Protein Binding/physiology
11.
Adv Exp Med Biol ; 1118: 63-70, 2019.
Article in English | MEDLINE | ID: mdl-30747417

ABSTRACT

Mental disorders, such as major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SZ), are generally characterized by a combination of abnormal thoughts, perceptions, emotions, behavior, and relationships with others. Multiple risk factors incorporating genetic and environmental susceptibility are associated with development of these disorders. Mitochondria have a central role in the energy metabolism, and the literature suggests energy metabolism abnormalities are widespread in the brains of subjects with MDD, BPD, and SZ. Numerous studies have shown altered expressions of mitochondria-related genes in these mental disorders. In addition, environmental factors for these disorders, such as stresses, have been suggested to induce mitochondrial abnormalities. Moreover, animal studies have suggested that interactions of altered expression of mitochondria-related genes and environmental factors might be involved in mental disorders. Further investigations into interactions of mitochondrial abnormalities with environmental factors are required to elucidate of the pathogenesis of these mental disorders.


Subject(s)
Energy Metabolism , Mental Disorders/metabolism , Mitochondria/pathology , Animals , Bipolar Disorder/metabolism , Bipolar Disorder/physiopathology , Depressive Disorder, Major/metabolism , Depressive Disorder, Major/physiopathology , Humans , Mental Disorders/physiopathology , Schizophrenia/metabolism , Schizophrenia/physiopathology
12.
Methods Mol Biol ; 1916: 41-48, 2019.
Article in English | MEDLINE | ID: mdl-30535680

ABSTRACT

Mental disorders such as major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SZ) are generally characterized by a combination of abnormal thoughts, perceptions, emotions, behavior, and relationships with others. Multiple risk factors incorporating genetic and environmental susceptibility are associated with development of these disorders. Mitochondria have a central role in the energy metabolism, and the literature suggests energy metabolism abnormalities are widespread in the brains of subjects with MDD, BD, and SZ. Numerous studies have shown altered expressions of mitochondria-related genes in these mental disorders. In addition, environmental factors for these disorders, such as stresses, have been suggested to induce mitochondrial abnormalities. Moreover, animal studies have suggested that interactions of altered expression of mitochondria-related genes and environmental factors might be involved in mental disorders. Further investigations into interactions of mitochondrial abnormalities with environmental factors are required to elucidate of the pathogenesis of these mental disorders.


Subject(s)
Brain/metabolism , Energy Metabolism/genetics , Mental Disorders/metabolism , Mitochondria/metabolism , Bipolar Disorder/genetics , Bipolar Disorder/metabolism , Bipolar Disorder/pathology , Brain/pathology , Depressive Disorder, Major/genetics , Depressive Disorder, Major/metabolism , Depressive Disorder, Major/pathology , Humans , Mental Disorders/genetics , Mental Disorders/pathology , Mitochondria/pathology , Risk Factors , Schizophrenia/genetics , Schizophrenia/metabolism , Schizophrenia/pathology
13.
Methods Mol Biol ; 1916: 149-155, 2019.
Article in English | MEDLINE | ID: mdl-30535692

ABSTRACT

Autism is a pervasive developmental disorder characterized by severe and sustained impairment of social interaction and communication, and restricted or stereotyped patterns of behavior and interest. Though multiple risk factors such as genetic and environmental components and interaction of these factors are suggested, the exact etiology is still not known. Many risk factors have been used to established animal models of psychiatric and neurodevelopmental disorders. These models can be useful tools for testing epidemiological findings and investigating the molecular mechanisms underlying the neuropathology of these disorders. To improve the validity of animal models, three criteria including behavioral similarity has been proposed. The method described here is for evaluating the impairment of social interaction, one of the three core symptoms of autism.


Subject(s)
Autism Spectrum Disorder/physiopathology , Autistic Disorder/physiopathology , Behavior, Animal , Disease Models, Animal , Animals , Autism Spectrum Disorder/genetics , Autistic Disorder/genetics , Child , Humans , Interpersonal Relations , Mice , Social Behavior
14.
Methods Mol Biol ; 1735: 231-238, 2018.
Article in English | MEDLINE | ID: mdl-29380316

ABSTRACT

Mental disorders are generally characterized by a combination of abnormal thoughts, perceptions, emotions, behavior, and relationships with others. Although multiple risk factors, such as genetic and environmental factors and interaction of these factors, are suggested, the exact etiologies are not known. On the other hand, it has been strongly suggested that the dopaminergic system is impaired in a variety of mental disorders. In the described method, the SH-SY5Y neuroblastoma cell line is differentiated to neuronal cell which expresses NSE, neuronal marker, and dopamine transporter (DAT) by treatment with all-trans-retinoic acid. SH-SY5Y cells allow investigating neuronal phenotypes of mental disorders as an in vitro model of these disorders.


Subject(s)
Mental Disorders/etiology , Mental Disorders/metabolism , Neurons/metabolism , Biomarkers , Cell Culture Techniques , Cell Differentiation , Cell Line , Cell Line, Tumor , Dopamine/metabolism , Dopamine Plasma Membrane Transport Proteins/metabolism , Gene Expression , Humans , Mental Disorders/psychology , Neurons/cytology
15.
Front Mol Neurosci ; 10: 341, 2017.
Article in English | MEDLINE | ID: mdl-29163023

ABSTRACT

Epidemiological studies suggest that obstetric complications, particularly those related to hypoxia during labor and delivery, are a risk factor for development of schizophrenia. The impact of perinatal asphyxia on postnatal life has been studied in a rodent model of global hypoxia, which is accompanied by cesarean section birth. This asphyxia model shows several behavioral, pharmacological, neurochemical, and neuroanatomical abnormalities in adulthood that have relevance to schizophrenia. Further, it is suggested that schizophrenia has a strong genetic component, and indeed novel candidate genes were recently identified by a genome-wide association study. Here, we examined alteration in the novel schizophrenia risk genes, CNNM2, CSMD1, and MMP16 in the brains of rats undergoing cesarean section with or without global hypoxia. The brain regions studied were the prefrontal cortex, striatum, and hippocampus, which are all relevant to schizophrenia. Risk gene expression was measured at three time periods: neonatal, adolescence, and adulthood. We also performed an in vitro analysis to determine involvement of these genes in CNS maturation during differentiation of human neuronal and glial cell lines. Cnnm2 expression was altered in the brains of asphyxia model rats. However, Csmd1 and Mmp16 showed altered expression by exposure to cesarean section only. These findings suggest that altered expression of these risk genes via asphyxia and cesarean section may be associated, albeit through distinct pathways, with the pathobiology of schizophrenia.

16.
Nihon Shokakibyo Gakkai Zasshi ; 114(8): 1454-1459, 2017.
Article in Japanese | MEDLINE | ID: mdl-28781356

ABSTRACT

Here we report a rare case of a reopened gastrostomy fistula 21-years after spontaneous closure. A male newborn underwent gastrostomy by laparotomy because of esophageal atresia shortly after birth. The gastrostomy tube was removed at 7 months old because he could consume enough oral nutrition. At the age of 21, however, the fistula reopened to form a labial fistula. When he consulted to our hospital, we observed a large skin sore with redness at the site of the fistula, which was caused by gastric outflow. We chose to resect the fistula by open surgery as a reliable therapeutic method in consideration of his future social life. The postoperative course was unremarkable.


Subject(s)
Esophageal Atresia/surgery , Gastrostomy , Gastric Fistula , Humans , Male , Remission, Spontaneous , Treatment Outcome , Young Adult
17.
Brain Behav Immun ; 61: 375-385, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28089559

ABSTRACT

Several studies have revealed that neuregulins (NRGs) are involved in brain function and psychiatric disorders. While NRGs have been regarded as neuron- or astrocyte-derived molecules, our research has revealed that microglia also express NRGs, levels of which are markedly increased in activated microglia. Previous studies have indicated that microglia are activated in the brains of individuals with autism spectrum disorder (ASD). Therefore, we investigated microglial NRG mRNA expression in multiple lines of mice considered models of ASD. Intriguingly, microglial NRG expression significantly increased in BTBR and socially-isolated mice, while maternal immune activation (MIA) mice exhibited identical NRG expression to controls. Furthermore, we observed a positive correlation between NRG expression in microglia and peripheral blood mononuclear cells (PBMCs) in mice, suggesting that NRG expression in human PBMCs may mirror microglia-derived NRG expression in the human brain. To translate these findings for application in clinical psychiatry, we measured levels of NRG1 splice-variant expression in clinically available PBMCs of patients with ASD. Levels of NRG1 type III expression in PBMCs were positively correlated with impairments in social interaction in children with ASD (as assessed using the Autistic Diagnostic Interview-Revised test: ADI-R). These findings suggest that immune cell-derived NRGs may be implicated in the pathobiology of psychiatric disorders such as ASD.


Subject(s)
Autism Spectrum Disorder/metabolism , Interpersonal Relations , Microglia/metabolism , Neuregulin-1/metabolism , Adolescent , Animals , Autism Spectrum Disorder/genetics , Brain/metabolism , Child , Disease Models, Animal , Humans , Leukocytes, Mononuclear/metabolism , Male , Mice , Neuregulin-1/genetics , Neurons/metabolism , Social Isolation
18.
Neurochem Int ; 104: 1-5, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28007470

ABSTRACT

Autism spectrum disorder is a neurodevelopmental disorder characterized by impaired social interaction, poor communication skills, and repetitive/restrictive behaviors. Elevated blood levels of pro-inflammatory cytokines have been reported in subjects with autism spectrum disorder. On the other hand, early childhood adverse experience also increases blood levels of these cytokines. Since social experience of children with autism spectrum disorder is generally unlike to typically developing children, we hypothesized that social interaction during childhood contribute to pro-inflammatory cytokine expression in subjects with autism spectrum disorder. We compared revised Autism Diagnostic Interview scores and expression levels of pro-inflammatory cytokines in peripheral blood mononuclear cells of subjects with autism spectrum disorder (n = 30). The score of domain A on the revised Autism Diagnostic Interview, indicating social interaction impairment in early childhood, was negatively correlated with tumor necrosis factor-α mRNA expression level in peripheral blood mononuclear cells but not interleukin-1ß or -6. Consistently, tumor necrosis factor-α mRNA expression was markedly low in subjects with autism spectrum disorder compared to typically developing children who presumably experienced the regular levels of social interaction. These findings suggest that the low blood levels of tumor necrosis factor-α mRNA in subjects with autism spectrum disorder might be due to impaired social interaction in early childhood.


Subject(s)
Autism Spectrum Disorder/blood , Interpersonal Relations , Leukocytes, Mononuclear/metabolism , Tumor Necrosis Factor-alpha/blood , Adolescent , Child , Cytokines/blood , Humans , Interleukin-1beta/blood , Tumor Necrosis Factor-alpha/genetics
19.
PLoS One ; 11(10): e0164425, 2016.
Article in English | MEDLINE | ID: mdl-27716787

ABSTRACT

Evidence suggests neuroprotective effects of fluoxetine, a selective serotonin reuptake inhibitor (SSRI), on the developed neurons in the adult brain. In contrast, the drug may be deleterious to immature or undifferentiated neural cells, although the mechanism is unclear. Recent investigations have suggested that microRNAs (miRNA) may be critical for effectiveness of psychotropic drugs including SSRI. We investigated whether fluoxetine could modulate expressions of neurologically relevant miRNAs in two neuroblastoma SK-N-SH and SH-SY5Y cell lines. Initial screening results revealed that three (miR-489, miR-572 and miR-663a) and four (miR-320a, miR-489, miR-572 and miR-663a) miRNAs were up-regulated in SK-N-SH cells and SH-SY5Y cells, respectively, after 24 hours treatment of fluoxetine (1-25 µM). Cell viability was reduced according to the dose of fluoxetine. The upregulation of miR-572 and miR-663a was consistent in both the SH-SY5Y and SK-N-SH cells, confirmed by a larger scale culture condition. Our data is the first in vitro evidence that fluoxetine could increase the expression of miRNAs in undifferentiated neural cells, and that putative target genes of those miRNAs have been shown to be involved in fundamental neurodevelopmental processes.


Subject(s)
Fluoxetine/pharmacology , MicroRNAs/genetics , Neuroblastoma/drug therapy , Neuroblastoma/genetics , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/genetics , Gene Expression Regulation, Neoplastic/drug effects , Gene Expression Regulation, Neoplastic/genetics , Humans , Neurogenesis/drug effects , Neurogenesis/genetics , Up-Regulation/drug effects , Up-Regulation/genetics
20.
Acta Neuropsychiatr ; 28(6): 352-356, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27321482

ABSTRACT

OBJECTIVE: Neuroimaging studies of depression considered as a stress-related disorder have shown uncoupling in regional cerebral blood flow (rCBF) and regional cerebral metabolic rate for glucose (rCMRglc). We hypothesised that the mismatch change of rCBF and rCMRglc could be a stress-related phenomenon. METHODS: We exposed male rats to 15-min period of forced swim (FS), followed by the measurement of rCBF using N-isopropyl-4-[123I] iodoamphetamine (123I-IMP) and rCMRglc using 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG). RESULTS: The uptake rate of 18F-FDG in the FS group showed a significant decrease in the prefrontal cortex (0.86±0.20%ID/g, p<0.01) and thalamus (0.77±0.17%ID/g, p<0.05) and tended to be lower in the hippocampus (0.58±0.13%ID/g) and cerebellum (0.59±0.13%ID/g) without overt alteration in the uptake rate of 123I-IMP. CONCLUSIONS: The FS stress can cause mismatch change of rCBF and rCMRglc, which reflect a stress-related phenomenon.


Subject(s)
Brain/metabolism , Cerebrovascular Circulation , Glucose/metabolism , Stress, Psychological/metabolism , Stress, Psychological/physiopathology , Animals , Brain/blood supply , Male , Rats , Rats, Sprague-Dawley , Swimming
SELECTION OF CITATIONS
SEARCH DETAIL
...